Delivery Order SPE2DB20D1004-SPE2DB24FE8U1

Award Date 11/14/23
Potential Completion Date 11/15/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract, valued at $3,850.94, is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,123.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award does not have a set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,033.98 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,037.43 firm fixed-price delivery order is for the procurement of 4557764424 - PRADAXA 150 MG CAPSULE UU 60S, with a period of performance through July 12, 2022. The award is not associated with a set-aside program and was issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,595.26, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 3, 2022 with an ultimate completion date of August 4, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $1,978.92 for the supply of PRADAXA 75 MG CAPSULE UU 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of January 19, 2022. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DX15D2208|SPE2DX22FMBQE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,798.94 delivery order is for the supply of 4555129144 units of the drug PRADAXA 150 MG CAPSULE UU 60S. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,203.80 firm fixed-price delivery order is for the supply of Pradaxa 75 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRADAXA 150 MG capsules. The contract, a Delivery Order worth $4,725.52, was awarded on November 8, 2022 with a completion date of November 9, 2022. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,277.95, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2022. The contract was awarded on February 27, 2022 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FE8U1
    Delivery Order

This federal contract award, valued at $1,940.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 11:01 AM